NCT05122975: A reported trial by RyCarma Therapeutics, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05122975 |
|---|---|
| Title | Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia Type 1 (CPVT1) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 1, 2023 |
| Completion date | April 1, 2024 |
| Required reporting date | April 1, 2025, midnight |
| Actual reporting date | March 27, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |